STK17A anticorps (AA 1-201)
Aperçu rapide pour STK17A anticorps (AA 1-201) (ABIN1885762)
Antigène
Voir toutes STK17A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-201
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 201 of DRAK1
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
-
Autre désignation
- DRAK1
-
Sujet
-
This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain.The protein has apoptosis-inducing activity.[provided by RefSeq]
-
Poids moléculaire
- 47 kDa
-
ID gène
- 9263
Antigène
-